Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosis.

Tennis P, Rothman KJ, Bohn RL, Tan H, Zavras A, Laskarides C, Calingaert B, Anthony MS.

Pharmacoepidemiol Drug Saf. 2012 Aug;21(8):810-7. doi: 10.1002/pds.3292.

PMID:
22711458
2.

Bisphosphonate-associated osteonecrosis of the jaw in Ontario: a survey of oral and maxillofacial surgeons.

Khan AA, Rios LP, Sándor GK, Khan N, Peters E, Rahman MO, Clokie CM, Dore E, Dubois S.

J Rheumatol. 2011 Jul;38(7):1396-402. doi: 10.3899/jrheum.100221.

PMID:
21498483
3.
4.

Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.

Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G, Koutsoukou V, Gika D, Anagnostopoulos A, Papadimitriou C, Terpos E, Dimopoulos MA.

J Clin Oncol. 2005 Dec 1;23(34):8580-7.

PMID:
16314620
5.

Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy.

Wang EP, Kaban LB, Strewler GJ, Raje N, Troulis MJ.

J Oral Maxillofac Surg. 2007 Jul;65(7):1328-31.

PMID:
17577497
6.

Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment.

Otto S, Schreyer C, Hafner S, Mast G, Ehrenfeld M, Stürzenbaum S, Pautke C.

J Craniomaxillofac Surg. 2012 Jun;40(4):303-9. doi: 10.1016/j.jcms.2011.05.003.

PMID:
21676622
7.

Long-term treatment with intravenous bisphosphonates in metastatic breast cancer: a retrospective study.

Brufsky AM, Sereika SM, Mathew A, Tomifumi O, Singh V, Rosenzweig M.

Breast J. 2013 Sep-Oct;19(5):504-11. doi: 10.1111/tbj.12152.

PMID:
23800050
8.

The national-scale cohort study on bisphosphonate-related osteonecrosis of the jaw in Taiwan.

Yuh DY, Chang TH, Huang RY, Chien WC, Lin FG, Fu E.

J Dent. 2014 Oct;42(10):1343-52. doi: 10.1016/j.jdent.2014.05.001.

PMID:
24907558
9.

Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S.

Skrepnek GH, Seal B, Tangirala M, Jeffcoat MK, Watts NB, Hay JW.

Gen Dent. 2010 Nov-Dec;58(6):484-92; quiz 493-4.

PMID:
21062718
10.

Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients.

Hoff AO, Toth B, Hu M, Hortobagyi GN, Gagel RF.

Ann N Y Acad Sci. 2011 Feb;1218:47-54. doi: 10.1111/j.1749-6632.2010.05771.x. Review.

PMID:
20946574
11.

Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis.

Rizzoli R, Burlet N, Cahall D, Delmas PD, Eriksen EF, Felsenberg D, Grbic J, Jontell M, Landesberg R, Laslop A, Wollenhaupt M, Papapoulos S, Sezer O, Sprafka M, Reginster JY.

Bone. 2008 May;42(5):841-7. doi: 10.1016/j.bone.2008.01.003. Review.

PMID:
18314405
12.

Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates.

Hoff AO, Toth BB, Altundag K, Johnson MM, Warneke CL, Hu M, Nooka A, Sayegh G, Guarneri V, Desrouleaux K, Cui J, Adamus A, Gagel RF, Hortobagyi GN.

J Bone Miner Res. 2008 Jun;23(6):826-36. doi: 10.1359/jbmr.080205.

13.

Bisphosphonate-induced osteonecrosis of the jaw (ONJ): Incidence and risk factors in patients with breast cancer and gynecological malignancies.

Fehm T, Beck V, Banys M, Lipp HP, Hairass M, Reinert S, Solomayer EF, Wallwiener D, Krimmel M.

Gynecol Oncol. 2009 Mar;112(3):605-9. doi: 10.1016/j.ygyno.2008.11.029.

PMID:
19136147
14.

A Large National Cohort Study of the Association between Bisphosphonates and Osteonecrosis of the Jaw in Patients with Osteoporosis: A Nested Case-control Study.

Kwon JW, Park EJ, Jung SY, Sohn HS, Ryu H, Suh HS.

J Dent Res. 2015 Sep;94(9 Suppl):212S-9S. doi: 10.1177/0022034515587862. Erratum in: J Dent Res. 2016 Jan;95(1):121.

PMID:
26001708
15.

Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures.

Lapi F, Cipriani F, Caputi AP, Corrao G, Vaccheri A, Sturkenboom MC, Di Bari M, Gregori D, Carle F, Staniscia T, Vestri A, Brandi M, Fusco V, Campisi G, Mazzaglia G; Bisphosphonates Efficacy-Safety Tradeoff (BEST) study group..

Osteoporos Int. 2013 Feb;24(2):697-705. doi: 10.1007/s00198-012-2013-y.

PMID:
22618266
16.

Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw.

Vahtsevanos K, Kyrgidis A, Verrou E, Katodritou E, Triaridis S, Andreadis CG, Boukovinas I, Koloutsos GE, Teleioudis Z, Kitikidou K, Paraskevopoulos P, Zervas K, Antoniades K.

J Clin Oncol. 2009 Nov 10;27(32):5356-62. doi: 10.1200/JCO.2009.21.9584.

PMID:
19805682
17.

Bisphosphonate-associated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patients.

Pozzi S, Marcheselli R, Sacchi S, Baldini L, Angrilli F, Pennese E, Quarta G, Stelitano C, Caparotti G, Luminari S, Musto P, Natale D, Broglia C, Cuoghi A, Dini D, Di Tonno P, Leonardi G, Pianezze G, Pitini V, Polimeno G, Ponchio L, Masini L, Musso M, Spriano M, Pollastri G; Gruppo Italiano Studio Linfomi..

Leuk Lymphoma. 2007 Jan;48(1):56-64.

PMID:
17325848
18.

Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome.

Yarom N, Yahalom R, Shoshani Y, Hamed W, Regev E, Elad S.

Osteoporos Int. 2007 Oct;18(10):1363-70.

PMID:
17598065
19.

Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges.

Solomon DH, Mercer E, Woo SB, Avorn J, Schneeweiss S, Treister N.

Osteoporos Int. 2013 Jan;24(1):237-44. doi: 10.1007/s00198-012-2042-6. Review.

PMID:
22707065
20.

Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results.

Jackson GH, Morgan GJ, Davies FE, Wu P, Gregory WM, Bell SE, Szubert AJ, Navarro Coy N, Drayson MT, Owen RG, Feyler S, Ashcroft AJ, Ross FM, Byrne J, Roddie H, Rudin C, Boyd KD, Osborne WL, Cook G, Child JA.

Br J Haematol. 2014 Jul;166(1):109-17. doi: 10.1111/bjh.12861.

PMID:
24673708
Items per page

Supplemental Content

Support Center